The immunological landscape in necrotising enterocolitis

Expert Reviews in Molecular Medicine

Volumn 18, Issue , 2016, Pages

  Cho, Steven X ^a,b   Berger, Philip J ^a,b   Nold Petry, Claudia A ^a,b   Nold, Marcel F ^a,b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN RECEPTOR; IMMUNOLOGIC FACTOR; PATTERN RECOGNITION RECEPTOR;

AGE; ANIMAL; CLINICAL TRIAL (TOPIC); CYTOLOGY; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; ENTEROCOLITIS, NECROTIZING; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGY; METABOLISM; OUTCOME ASSESSMENT; PHENOTYPE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

AGE FACTORS; ANIMALS; BIOMARKERS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; ENTEROCOLITIS, NECROTIZING; HUMANS; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGIC FACTORS; PATIENT OUTCOME ASSESSMENT; PHENOTYPE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PATTERN RECOGNITION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

EID: 84976330093     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/erm.2016.13     Document Type: Review

References (195)

1. Al Tawil K. et al. (2013) Risk factors, characteristics and outcomes of necrotizing enterocolitis in late preterm and term infants. Journal of Neonatal-Perinatal Medicine 6, 125-130
2. Patel R.M. et al. (2015) Causes and timing of death in extremely premature infants from 2000 through 2011. New England Journal of Medicine 372, 331-340
3. Henry M.C. and Moss R.L. (2009) Necrotizing enterocolitis. Annual Review of Medicine 60, 111-124
4. Stoll B.J. et al. (2010) Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 126, 443-456
5. Fitzgibbons S.C. et al. (2009) Mortality of necrotizing enterocolitis expressed by birth weight categories. Journal of Pediatric Surgery 44, 1072-1075; discussion 75-6
6. Blakely M.L. et al. (2005) Postoperative outcomes of extremely low birth-weight infants with necrotizing enterocolitis or isolated intestinal perforation: a prospective cohort study by the NICHD Neonatal Research Network. Annals of Surgery 241, 984-989; discussion 89-94
7. ANZNN (Australian and New Zealand Neonatal Network). (2012) Report of the Australian and New Zealand Neonatal Network 2008 and 2009. Sydney: ANZNN.
8. Hall N.J., Eaton S. and Pierro A. (2013) Royal Australasia of Surgeons Guest Lecture. Necrotizing enterocolitis: prevention, treatment, and outcome. Journal of Pediatric Surgery 48, 2359-2367
9. Bell M.J. et al. (1978) Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery 187, 1-7
10. Walsh M.C. and Kliegman R.M. (1986) Necrotizing enterocolitis: treatment based on staging criteria. Pediatric Clinics of North America 33, 179-201
11. Bisquera J.A., Cooper T.R. and Berseth C.L. (2002) Impact of necrotizing enterocolitis on length of stay and hospital charges in very low birth weight infants. Pediatrics 109, 423-428
12. Ganapathy V., Hay J.W. and Kim J.H. (2012) Costs of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants. Breastfeeding Medicine: the Official Journal of the Academy of Breastfeeding Medicine 7, 29-37
13. Pike K. et al. (2012) Outcomes at 7 years for babies who developed neonatal necrotising enterocolitis: the ORACLE Children Study. Archives of disease in childhood. Fetal and Neonatal Edition 97, F318-F322
14. Schulzke S.M., Deshpande G.C. and Patole S.K. (2007) Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis: a systematic review of observational studies. Archives of Pediatrics & Adolescent Medicine 161, 583-590
15. Hintz S.R. et al. (2005) Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 115, 696-703
16. Murthy K. et al. (2014) Short-term outcomes for preterm infants with surgical necrotizing enterocolitis. Journal of Perinatology: Official Journal of the California Perinatal Association 34, 736-740
17. Luig M. and Lui K. (2005) Epidemiology of necrotizing enterocolitis. Part II. Risks and susceptibility of premature infants during the surfactant era: a regional study. Journal of Paediatrics and Child Health 41, 174-179
18. Buch N.A. et al. (2001) An epidemiological study of neonatal necrotizing enterocolitis. Saudi Medical Journal 22, 231-237
19. Guthrie S.O. et al. (2003) Necrotizing enterocolitis among neonates in the United States. Journal of Perinatology: Official Journal of the California Perinatal Association 23, 278-285
20. McElroy S.J. and Weitkamp J.H. (2011) Innate immunity in the small intestine of the preterm infant. Neoreviews 12, e517-e526
21. Battersby A.J. and Gibbons D.L. (2013) The gut mucosal immune system in the neonatal period. Pediatric Allergy and Immunology 24, 414-421
22. Neu J. (2007) Gastrointestinal development and meeting the nutritional needs of premature infants. American Journal of Clinical Nutrition 85, 629S-634S
23. Bianchi M.E. (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. Journal of Leukocyte Biology 81, 1-5
24. Schanler R.J., Shulman R.J. and Lau C. (1999) Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics 103(6 Pt 1), 1150-1157
25. Schanler R.J. et al. (2005) Randomized trial of donor human milk versus preterm formula as substitutes for mothers’ own milk in the feeding of extremely premature infants. Pediatrics 116, 400-406
26. Quigley M. and McGuire W. (2014) Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database of Systematic Reviews 4, CD002971
27. Penn A.H. et al. (2012) Digested formula but not digested fresh human milk causes death of intestinal cells in vitro: implications for necrotizing enterocolitis. Pediatric Research 72, 560-567
28. Chatterton D.E. et al. (2013) Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. International Journal of Biochemistry & Cell Biology 45, 1730-1747
29. Castanys-Munoz E., Martin M.J. and Vazquez E. (2016) Building a beneficial microbiome from birth. Advances in Nutrition 7, 323-330
30. Ballance W.A. et al. (1990) Pathology of neonatal necrotizing enterocolitis: a ten-year experience. Journal of pediatrics 117(1 Pt 2), S6-S13
31. Lambert D.K. et al. (2007) Necrotizing enterocolitis in term neonates: data from a multihospital health-care system. Journal of Perinatology: Official Journal of the California Perinatal Association 27, 437-443
32. Fisher J.G. et al. (2014) Serious congenital heart disease and necrotizing enterocolitis in very low birth weight neonates. Journal of the American College of Surgeons 220, 1018-1026
33. Uauy R.D. et al. (1991) Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. The Journal of Pediatrics 119, 630-638
34. Maynard C.L. et al. (2012) Reciprocal interactions of the intestinal microbiota and immune system. Nature 489, 231-241
35. Wang Y. et al. (2009) 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME Journal 3, 944-954
36. Sangild P.T. et al. (2006) Diet- and colonization-dependent intestinal dysfunction predisposes to necrotizing enterocolitis in preterm pigs. Gastroenterology 130, 1776-1792
37. Sodhi C.P. et al. (2012) Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. Gastroenterology 143, 708-718 e1-5
38. Bousseboua H. et al. (1989) Experimental cecitis in gnotobiotic quails monoassociated with Clostridium butyricum strains isolated from patients with neonatal necrotizing enterocolitis and from healthy newborns. Infection and Immunity 57, 932-936
39. Waligora-Dupriet A.J. et al. (2005) Evidence for clostridial implication in necrotizing enterocolitis through bacterial fermentation in a gnotobiotic quail model. Pediatric Research 58, 629-635
40. Azcarate-Peril M.A. et al. (2011) Acute necrotizing enterocolitis of preterm piglets is characterized by dysbiosis of ileal mucosa-associated bacteria. Gut Microbes 2, 234-243
41. Cassir N. et al. (2015) Clostridium butyricum strains and Dysbiosis linked to Necrotizing Enterocolitis in preterm Neonates. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 61, 1107-15
42. Lu P. et al. (2014) Animal models of gastrointestinal and liver diseases. Animal Models of Necrotizing Enterocolitis: Pathophysiology, Translational Relevance, and Challenges. American Journal of Physiology. Gastrointestinal and Liver Physiology 306, G917-G928
43. Barlow B. et al. (1974) An experimental study of acute neonatal enterocolitis-the importance of breast milk. Journal of Pediatric Surgery 9, 587-595
44. Premkumar M.H. et al. (2014) Argininosuccinate lyase in enterocytes protects from development of necrotizing enterocolitis. American Journal of Physiology – Gastrointestinal and Liver Physiology 307, G347-G354
45. Tian R. et al. (2010) Characterization of a necrotizing enterocolitis model in newborn mice. International Journal of Clinical and Experimental Medicine 3, 293-302
46. Good M. et al. (2014) Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9. American Journal of Physiology – Gastrointestinal and Liver Physiology 306, G1021-G1032
47. MohanKumar K. et al. (2012) Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model. American Journal of Physiology – Gastrointestinal and Liver Physiology 303, G93-102
48. Zhang C. et al. (2012) Paneth cell ablation in the presence of Klebsiella pneumoniae induces necrotizing enterocolitis (NEC)-like injury in the small intestine of immature mice. Disease Models & Mechanisms 5, 522-532
49. Emami C.N. et al. (2012) Role of neutrophils and macrophages in the pathogenesis of necrotizing enterocolitis caused by Cronobacter sakazakii. Journal of Surgical Research 172, 18-28
50. Namachivayam K. et al. (2013) Smad7 inhibits autocrine expression of TGF-beta2 in intestinal epithelial cells in baboon necrotizing enterocolitis. American Journal of Physiology – Gastrointestinal and Liver Physiology 304, G167-G180
51. Butel M.J. et al. (1998) Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria. Journal of Medical Microbiology 47, 391-399
52. Dowling D.J. and Levy O. (2014) Ontogeny of early life immunity. Trends in Immunology 35, 299-310
53. Levy O. (2007) Innate immunity of the newborn: basic mechanisms and clinical correlates. Nature Reviews Immunology 7, 379-390
54. Sharma A.A. et al. (2012) The developing human preterm neonatal immune system: a case for more research in this area. Clinical Immunology 145, 61-68
55. Jones C.A., Holloway J.A. and Warner J.O. (2002) Phenotype of fetal monocytes and B lymphocytes during the third trimester of pregnancy. Journal of Reproductive Immunology 56, 45-60
56. Strunk T. et al. (2004) Differential maturation of the innate immune response in human fetuses. Pediatric Research 56, 219-226
57. Kumar H., Kawai T. and Akira S. (2011) Pathogen recognition by the innate immune system. International Review of Immunology 30, 16-34
58. Abreu M.T. (2010) Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nature Reviews Immunology 10, 131-144
59. Gribar S.C. et al. (2009) Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. Journal of Immunology 182, 636-646
60. Lotz M. et al. (2006) Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. Journal of Experimental Medicine 203, 973-984
61. Nanthakumar N. et al. (2011) The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS ONE 6, e17776
62. Chan K.Y. et al. (2014) Genome-wide expression profiles of Necrotizing Enterocolitis versus spontaneous intestinal perforation in human intestinal tissues: dysregulation of functional pathways. Annals of Surgery 260, 1128-1137
63. Leaphart C.L. et al. (2007) A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. Journal of Immunology 179, 4808-4820
64. He Y., Lawlor N.T. and Newburg D.S. (2016) Human milk components modulate toll-like receptor-mediated inflammation. Advances in Nutrition 7, 102-111
65. Good M. et al. (2015) Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor. Mucosal Immunology 8, 1166-1179
66. Neal M.D. et al. (2012) Toll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosis. Journal of Biological Chemistry 287, 37296-37308
67. Afrazi A. et al. (2014) Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis. Journal of Biological Chemistry 289, 9584-9599
68. Neal M.D. et al. (2013) Discovery and validation of a new class of small molecule Toll-like receptor 4 (TLR4) inhibitors. PLoS ONE 8, e65779
69. Egan C.E. et al. (2015) Toll-like receptor 4-mediated lymphocyte influx induces neonatal necrotizing enterocolitis. Journal of Clinical Investigation
70. Liu Y. et al. (2009) Changes in intestinal Toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitis. American Journal of Physiology – Gastrointestinal and Liver Physiology 297, G442-G450
71. Le Mandat Schultz A. et al. (2007) Expression of TLR-2, TLR-4, NOD2 and pNF-kappaB in a neonatal rat model of necrotizing enterocolitis. PLoS ONE 2, e1102
72. Vijay-Kumar M. et al. (2007) Deletion of TLR5 results in spontaneous colitis in mice. Journal of Clinical Investigation 117, 3909-3921
73. Carvalho F.A. et al. (2012) Interleukin-1beta (IL-1beta) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis. Gut 61, 373-384
74. van Aubel R.A. et al. (2007) Ligand-induced differential cross-regulation of Toll-like receptors 2, 4 and 5 in intestinal epithelial cells. Molecular Immunology 44, 3702-3714
75. Voss E. et al. (2006) NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. Journal of Biological Chemistry 281, 2005-2011
76. Philpott D.J. et al. (2014) NOD proteins: regulators of inflammation in health and disease. Nature Reviews Immunology 14, 9-23
77. Richardson W.M. et al. (2010) Nucleotide-binding oligomer-ization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium. Gastroenterology 139, 904-917, 17 e1-6
78. Hugot J.P. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603
79. Ogura Y. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606
80. Hartel C. et al. (2016) NOD2 loss-of-function mutations and risks of necrotizing Enterocolitis or focal intestinal perforation in very low-birth-weight Infants. Inflammatory Bowel Diseases 22, 249-256
81. Dinarello C.A., Simon A. and van der Meer J.W. (2012) Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nature Reviews Drug Discovery 11, 633-652
82. Siggers J. et al. (2011) Transition from parenteral to enteral nutrition induces immediate diet-dependent gut histological and immunological responses in preterm neonates. American Journal of Physiology – Gastrointestinal and Liver Physiology 301, G435-G445
83. Siggers J. et al. (2013) Postnatal amniotic fluid intake reduces gut inflammatory responses and necrotizing enterocolitis in preterm neonates. American Journal of Physiology – Gastrointestinal and Liver Physiology 304, G864-G875
84. Guven A. et al. (2011) Melatonin ameliorates necrotizing enterocolitis in a neonatal rat model. Journal of Pediatric Surgery 46, 2101-2107
85. Yurttutan S. et al. (2013) Protective effects of colchicine in an experimental model of necrotizing enterocolitis in neonatal rats. Journal of Surgical Research 183, 156-162
86. Weitkamp J.H. et al. (2013) Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut 62, 73-82
87. Viscardi R.M. et al. (1997) Inflammatory cytokine mRNAs in surgical specimens of necrotizing enterocolitis and normal newborn intestine. Pediatric Pathology & Laboratory Medicine: Journal of the Society for Pediatric Pathology, Affiliated with the International Paediatric Pathology Association 17, 547-559
88. Benkoe T. et al. (2013) Comprehensive evaluation of 11 cytokines in premature infants with surgical necrotizing enterocolitis. PLoS ONE 8, e58720
89. Edelson M.B., Bagwell C.E. and Rozycki H.J. (1999) Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 103(4 Pt 1), 766-771
90. Murgas Torrazza R. et al. (2013) Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants. Neonatology 104, 234-242
91. Caplan M.S. et al. (1990) Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. Journal of Pediatrics 116, 960-964
92. Baregamian N. et al. (2009) Tumor necrosis factor-alpha and apoptosis signal-regulating kinase 1 control reactive oxygen species release, mitochondrial autophagy, and c-Jun N-terminal kinase/p38 phosphorylation during necrotizing enterocolitis. Oxidative Medicine and Cellular Longevity 2, 297-306
93. Harris M.C. et al. (1994) Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. Journal of Pediatrics 124, 105-111
94. Morecroft J.A. et al. (1994) Plasma cytokine levels in necrotizing enterocolitis. Acta Paediatrica 396, 18-20
95. Morecroft J.A. et al. (1994) Plasma interleukin-6 and tumour necrosis factor levels as predictors of disease severity and outcome in necrotizing enterocolitis. Journal of Pediatric Surgery 29, 798-800
96. Sheng Q. et al. (2014) Human beta-defensin-3 promotes intestinal epithelial cell migration and reduces the development of necrotizing enterocolitis in a neonatal rat model. Pediatric Research 76, 269-279
97. Cetinkaya M. et al. (2013) CDP-choline reduces severity of intestinal injury in a neonatal rat model of necrotizing enterocolitis. Journal of Surgical Research 183, 119-128
98. Seitz G. et al. (2005) Protective effect of tumor necrosis factor alpha antibody on experimental necrotizing enterocolitis in the rat. Journal of Pediatric Surgery 40, 1440-1445
99. Rentea R.M. et al. (2013) Early enteral stressors in newborns increase inflammatory cytokine expression in a neonatal necrotizing enterocolitis rat model. European Journal of Pediatric Surgery:Official Journal of Austrian Association of Pediatric Surgery = Zeitschrift fur Kinderchirurgie 23, 39-47
100. Nadler E.P. et al. (2000) Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. Journal of Surgical Research 92, 71-77
101. Halpern M.D. et al. (2006) Reduction of experimental necrotizing enterocolitis with anti-TNF-alpha. American Journal of Physiology – Gastrointestinal and Liver Physiology 290, G757-G764
102. Travadi J. et al. (2006) Pentoxifylline reduces the incidence and severity of necrotizing enterocolitis in a neonatal rat model. Pediatric Research 60, 185-189
103. Yurttutan S. et al. (2014) Beneficial effects of Etanercept on experimental necrotizing enterocolitis. Pediatric Surgery International 30, 71-77
104. Tayman C. et al. (2016) TNF-alpha blockade efficiently reduced severe intestinal damage in necrotizing enterocolitis. Journal of Investigative Surgery 18, 1-9
105. Erdener D. et al. (2004) Pentoxifylline does not prevent hypoxia/reoxygenation-induced necrotizing enterocolitis. An experimental study. Biology of the Neonate 86, 29-33
106. Tanaka T. and Kishimoto T. (2014) The biology and medical implications of interleukin-6. Cancer Immunology Research 2, 288-294
107. Kilpinen S. et al. (2001) The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. European Cytokine Network 12, 62-68
108. Franklin A.L. et al. (2015) Are immune modulating single nucleotide polymorphisms associated with necrotizing enterocolitis? Scientific Reports 5, 18369
109. Ren Y. et al. (2005) Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis. Histopathology 46, 659-667
110. Chan K.Y. et al. (2012) Immunoregulatory protein profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in preterm infants. PLoS ONE 7, e36977
111. Kotlarz D. et al. (2012) Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology 143, 347-355
112. Kuhn R. et al. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274
113. Zigmond E. et al. (2014) Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity 40, 720-733
114. + T cells during cure of colitis. Journal of Immunology 177, 5852-5860
115. + regulatory T cells in the intestine and mesenteric lymph node in experimental necrotizing enterocolitis. PLoS ONE 8, e56547
116. Emami C.N. et al. (2012) Role of interleukin-10 in the pathogenesis of necrotizing enterocolitis. American Journal of Surgery 203, 428-435
117. Garofalo R. et al. (1995) Interleukin-10 in human milk. Pediatric Research 37(4 Pt 1), 444-449
118. Fituch C.C. et al. (2004) Concentrations of IL-10 in preterm human milk and in milk from mothers of infants with necrotizing enterocolitis. Acta Paediatrica 93, 1496-1500
119. Dembinski J. et al. (2003) Modulation of pro- and anti-inflammatory cytokine production in very preterm infants. Cytokine 21, 200-206
120. Blanco-Quiros A. et al. (2000) Cord blood interleukin-10 levels are increased in preterm newborns. European Journal of Pediatrics 159, 420-423
121. Lavoie P.M. et al. (2010) Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis. Journal of Infectious Diseases 202, 1754-1763
122. + regulatory T lymphocytes and of cytokine secretions in infants born prematurely. Journal of Clinical Immunology 33, 1126-1133
123. Li Q. and Verma I.M. (2002) NF-kappaB regulation in the immune system. Nature Reviews Immunology 2, 725-734
124. Claud E.C. et al. (2004) Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagel-lin-induced inflammation. Proceedings of the National Academy of Sciences of the United States of America 101, 7404-7408
125. De Plaen I.G. et al. (2007) Inhibition of nuclear factor-kappaB ameliorates bowel injury and prolongs survival in a neonatal rat model of necrotizing enterocolitis. Pediatric Research 61, 716-721
126. Yee W.H. et al. (2012) Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics 129, e298-e304
127. Adamzik M. et al. (2013) The NFKB1 promoter polymorphism (-94ins/delATTG) alters nuclear translocation of NF-kappaB1 in monocytes after lipopolysaccharide stimulation and is associated with increased mortality in sepsis. Anesthesiology 118, 123-133
128. Sampath V. et al. (2011) The NFKB1 (g.-24519delATTG) variant is associated with necrotizing enterocolitis (NEC) in premature infants. Journal of Surgical Research 169, e51-e57
129. O'Neill L.A. and Bowie A.G. (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Reviews Immunology 7, 353-364
130. Yang G. et al. (2014) Critical role of myeloid differentiation factor 88 in necrotizing enterocolitis. Pediatric Research 75, 707-715
131. Garlanda C. et al. (2013) Negative regulatory receptors of the IL-1 family. Seminars in Immunology 25, 408-415
132. Nold-Petry C.A. et al. (2015) IL-37 requires the receptors IL-18Ralpha and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nature Immunology 16, 354-365
133. Sampath V. et al. (2015) SIGIRR genetic variants in premature infants with necrotizing enterocolitis. Pediatrics 135, e1530-4
134. Remon J.I. et al. (2015) Depth of bacterial invasion in resected intestinal tissue predicts mortality in surgical necrotizing enterocolitis. Journal of Perinatology 35, 755-762
135. Tremblay E. et al. (2016) Gene expression profiling in necrotizing enterocolitis reveals pathways common to those reported in Crohn's disease. BMC Medical Genomics 9, 6
136. Schoenborn J.R. and Wilson C.B. (2007) Regulation of interferon-gamma during innate and adaptive immune responses. Advances in Immunology 96, 41-101
137. Basha S., Surendran N. and Pichichero M. (2014) Immune responses in neonates. Expert Review of Clinical Immunology 10, 1171-1184
138. Abdelhamid A.E. et al. (2011) In vitro cow's milk protein-specific inflammatory and regulatory cytokine responses in preterm infants with necrotizing enterocolitis and sepsis. Pediatric Research 69, 165-169
139. Ford H. et al. (1997) The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. Journal of Pediatric Surgery 32, 275-282
140. Pender S.L. et al. (2003) Matrix metalloproteinases in necrotising enterocolitis. Pediatric Research 54, 160-164
141. Leaphart C.L. et al. (2007) Interferon-gamma inhibits intestinal restitution by preventing gap junction communication between enterocytes. Gastroenterology 132, 2395-2411
142. Coursodon-Boyiddle C.F. et al. (2012) Pomegranate seed oil reduces intestinal damage in a rat model of necrotizing enterocolitis. American Journal of Physiology – Gastrointestinal and Liver Physiology 303, G744-G751
143. Halpern M.D. et al. (2002) Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatric Research 51, 733-739
144. +874A and interleukin 12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonates. Archives of Disease in Childhood. Fetal and Neonatal Edition 92, F25-F29
145. Akdis M. et al. (2011) Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. Journal of Allergy and Clinical Immunology 127, 701-721 e1-70
146. Halpern M.D. et al. (2003) Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor. Journal of Pediatric Gastroenterology and Nutrition 36, 126-133
147. Halpern M.D. et al. (2008) Decreased development of necrotizing enterocolitis in IL-18-deficient mice. American Journal of Physiology – Gastrointestinal and Liver Physiology 294, G20-G26
148. Heninger E. et al. (2002) Genetic variants of the interleukin-18 promoter region (-607) influence the course of necrotising enterocolitis in very low birth weight neonates. European Journal of Pediatrics 161, 410-411
149. Maheshwari A. et al. (2014) Cytokines associated with necrotizing enterocolitis in extremely-low-birth-weight infants. Pediatric Research 76, 100-108
150. Calhoun D.A. et al. (2000) Granulocyte-macrophage colony-stimulating factor and interleukin-5 concentrations in premature neonates with eosinophilia. Journal of Perinatology: Official Journal of the California Perinatal Association 20, 166-171
151. Treszl A. et al. (2003) Lower prevalence of IL-4 receptor alpha-chain gene G variant in very-low-birth-weight infants with necrotizing enterocolitis. Journal of Pediatric Surgery 38, 1374-1378
152. Mannon P. and Reinisch W. (2012) Interleukin 13 and its role in gut defence and inflammation. Gut 61, 1765-1773
153. Khor B., Gardet A. and Xavier R.J. (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307-317
154. Underwood M.A. et al. (2014) Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota. Pediatric Research 76, 326-333
155. Weitkamp J.H. et al. (2014) Small intestinal intraepithelial TCRgammadelta+ T lymphocytes are present in the premature intestine but selectively reduced in surgical necrotizing enterocolitis. PLoS ONE 9, e99042
156. Brandtzaeg P. (2003) Mucosal immunity: integration between mother and the breast-fed infant. Vaccine 21, 3382-3388
157. Rubaltelli F.F., Benini F. and Sala M. (1991) Prevention of necrotizing enterocolitis in neonates at risk by oral administration of monomeric IgG. Developmental Pharmacology & Therapeutics 17, 138-143
158. Eibl M.M. et al. (1988) Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA–IgG feeding. New England Journal of Medicine 319, 1-7
159. Lawrence G. et al. (2001) Enteral human IgG for prevention of necrotising enterocolitis: a placebo-controlled, randomised trial. Lancet 357, 2090-2094
160. Foster J.P., Cole M.J. and Seth R. (2016) Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates. Cochrane Database of Systematic Reviews 4, CD001816
161. Ohlsson A. and Lacy J.B. (2013) Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 7, CD000361
162. Nanthakumar N.N. et al. (2000) Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proceedings of the National Academy of Sciences of the United States of America 97, 6043-6048
163. Gibbons D. et al. (2014) Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nature Medicine 20, 1206-1210
164. Nadler E.P. et al. (2001) Intestinal cytokine gene expression in infants with acute necrotizing enterocolitis: interleukin-11 mRNA expression inversely correlates with extent of disease. Journal of Pediatric Surgery 36, 1122-1129
165. Travis M.A. and Sheppard D. (2014) TGF-beta activation and function in immunity. Annual Review of Immunology 32, 51-82
166. Maheshwari A. et al. (2011) TGF-beta2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology 140, 242-253
167. Shiou S.R. et al. (2013) Oral administration of transforming growth factor-beta1 (TGF-beta1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor kappaB (NF-kappaB) signaling and proinflammatory cytokine production. Journal of Biological Chemistry 288, 34757-34766
168. Nguyen D.N. et al. (2014) Transforming growth factor-beta2 and endotoxin interact to regulate homeostasis via interleukin-8 levels in the immature intestine. American Journal of Physiology – Gastrointestinal and Liver Physiology 307, G689-G699
169. Nguyen D.N. et al. (2015) Protective effects of transforming growth factor beta2 in intestinal epithelial cells by regulation of proteins associated with stress and endotoxin responses. PLoS ONE 10, e0117608
170. Izumi T. and Shimizu T. (1995) Platelet-activating factor receptor: gene expression and signal transduction. Biochimica et Biophysica Acta 1259, 317-333
171. De Plaen I.G. et al. (2000) Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor. British Journal of Pharmacology 129, 307-314
172. Hsueh W. et al. (2003) Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatric and Developmental Pathology 6, 6-23
173. MacKendrick W. et al. (1993) Increase in plasma platelet-activating factor levels in enterally fed preterm infants. Biology of the Neonate 64, 89-95
174. Amer M.D. et al. (2004) Platelet-activating factor concentration in the stool of human newborns: effects of enteral feeding and neonatal necrotizing enterocolitis. Biology of the Neonate 85, 159-166
175. Caplan M. et al. (1990) Serum PAF acetylhydrolase increases during neonatal maturation. Prostaglandins 39, 705-714
176. Moya F.R. et al. (1994) Platelet-activating factor acetylhydrolase in term and preterm human milk: a preliminary report. Journal of Pediatric Gastroenterology and Nutrition 19, 236-239
177. Lu J. et al. (2010) Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis. Pediatric Research 68, 225-230
178. Caplan M.S. et al. (1997) The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatric Research 42, 779-783
179. Caplan M.S. et al. (1997) The platelet-activating factor receptor antagonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats. Journal of Pediatric Gastroenterology and Nutrition 24, 296-301
180. Ewer A.K. et al. (2004) The role of platelet activating factor in a neonatal piglet model of necrotising enterocolitis. Gut 53, 207-213
181. Ng P.C., Ma T.P. and Lam H.S. (2015) The use of laboratory biomarkers for surveillance, diagnosis and prediction of clinical outcomes in neonatal sepsis and necrotising enterocolitis. Archives of Disease in Childhood. Fetal and Neonatal Edition 100, F448-F452
182. Bhatia A.M. et al. (2014) Cytokine levels in the preterm infant with neonatal intestinal injury. American Journal of Perinatology 31, 489-496
183. Ng P.C. et al. (2006) Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clinical Chemistry 52, 1181-1189
184. Gregory K.E. et al. (2014) Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis. Journal of Pediatrics 164, 1486-1488
185. Edelson M.B. et al. (1999) Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: a pilot study. Journal of Pediatric Surgery 34, 1453-1457
186. Schurink M. et al. (2015) Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: a prospective cohort study. PLoS ONE 10, e0121336
187. Harris M.C. et al. (2005) Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entercolitis, or sepsis syndrome: correlation with clinical parameters of inflammation and mortality. Journal of Pediatrics 147, 462-468
188. Benkoe T. et al. (2014) Interleukin-8 predicts 60-day mortality in premature infants with necrotizing enterocolitis. Journal of Pediatric Surgery 49, 385-389
189. Benkoe T. et al. (2012) Interleukin 8 correlates with intestinal involvement in surgically treated infants with necrotizing enterocolitis. Journal of Pediatric Surgery 47, 1548-1554
190. Chaaban H. et al. (2010) Inter-alpha inhibitor protein level in neonates predicts necrotizing enterocolitis. Journal of Pediatrics 157, 757-761
191. Yoon J.M. et al. (2014) Fecal calprotectin concentration in neonatal necrotizing enterocolitis. Korean Journal of Pediatrics 57, 351-356
192. Albanna E.A., Ahmed H.S. and Awad H.A. (2014) Stool calprotectin in necrotizing enterocolitis. Journal of Clinical Neonatoloy 3, 16-19
193. Bin-Nun A. et al. (2015) Rapid fecal calprotectin (FC) analysis: point of care testing for diagnosing early necrotizing enterocolitis. American Journal of Perinatology 32, 337-342
194. Ng P.C. et al. (2010) Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. Journal of Clinical Investigation 120, 2989-3000
195. Ng E.W. et al. (2013) Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Annals of Surgery 258, 1111-1118